Global Digital Respiratory Devices Market (2021 to 2030) - Featuring 3M, Adherium and Amiko Digital Health Among Others
April 16, 2021 06:03 ET
|
Research and Markets
Dublin, April 16, 2021 (GLOBE NEWSWIRE) -- The "Global Digital Respiratory Devices Market 2021-2030: Focus on Sensors, Smart Inhalers & Nebulizers, Application, 9 Countries' Data, and...
Outlook on the Portable Compressor Nebulizer Global Market to 2025 - Cumulative Impact of COVID-19
March 22, 2021 09:08 ET
|
Research and Markets
Dublin, March 22, 2021 (GLOBE NEWSWIRE) -- The "Portable Compressor Nebulizer Market Research Report by Type (Mesh Nebulizer, Pneumatic Nebulizer, and Ultrasonic Nebulizer), by Distribution Channel...
With Monaghan Medical, Safe Nebulizer Therapy is Possible
February 23, 2021 08:40 ET
|
Monaghan Medical Corporation
PLATTSBURGH, N.Y., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Monaghan Medical Corporation wants you to know that you can create a safer environment when delivering nebulizer therapy. Nebulizer therapy is a...
Nasal delivery devices Market Forecast to 2027: Global COVID-19 Impact and Analysis by Drug Type, Delivery Technologies, End User
November 24, 2020 02:48 ET
|
Research and Markets
Dublin, Nov. 24, 2020 (GLOBE NEWSWIRE) -- The "Nasal delivery devices Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Drug Type; Delivery Technologies; End User, and Geography"...
Global $39.96 Billion Pulmonary Devices Market to 2027: Consumables and Accessories to Grow at the Highest Rate
November 20, 2020 07:33 ET
|
Research and Markets
Dublin, Nov. 20, 2020 (GLOBE NEWSWIRE) -- The "Pulmonary Devices Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Type; Application; End User, and Geography" report has been added to...
InCarda Therapeutics Presents Positive New Data from Phase 2 Study of InRhythm™ in Patients with Paroxysmal Atrial Fibrillation at American Heart Association Scientific Sessions 2020
November 13, 2020 10:00 ET
|
InCarda Therapeutics, Inc.
Data Demonstrate Achievement of Rapid Conversions from Atrial Fibrillation to Normal Sinus Rhythm Study Findings Provide Proof of Concept for First-of-its-Kind Inhaled Antiarrhythmic for Treatment of...
InCarda Therapeutics Raises $30 Million Through First Close of Series C Equity Financing
October 21, 2020 08:05 ET
|
InCarda Therapeutics, Inc.
Proceeds to Support Ongoing Clinical Development of InRhythm™, A First-of-its-Kind Inhaled Antiarrhythmic for Treatment of Paroxysmal Atrial Fibrillation (PAF) Positive Phase 2 Data Scheduled for...
Worldwide Industry for Aerosol Delivery Devices to 2027 - Increase in Prevalence of COPD and Asthma is Driving Growth
October 16, 2020 05:28 ET
|
Research and Markets
Dublin, Oct. 16, 2020 (GLOBE NEWSWIRE) -- The "Aerosol Delivery Devices Market by Product, Application and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2020-2027" report...
$248.22 Million Smart Inhalers Markets - Global Forecast to 2025 with COVID-19 Impact Assessment
October 16, 2020 01:33 ET
|
Research and Markets
Dublin, Oct. 16, 2020 (GLOBE NEWSWIRE) -- The "Smart Inhalers Market Research Report by Product Type, by Distribution Channel - Global Forecast to 2025 - Cumulative Impact of COVID-19" report has...
Asia-Pacific Respiratory Devices Market Report 2020-2025: Market Breakdown by Diagnostic and Monitoring Devices, Therapeutic Devices & Disposables
October 14, 2020 04:14 ET
|
Research and Markets
Dublin, Oct. 14, 2020 (GLOBE NEWSWIRE) -- The "Asia-Pacific Respiratory Devices Market - Growth, Trends, and Forecasts (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering. ...